Epigenetic disruption of cadherin-11 in human cancer metastasis

Journal of Pathology

Volumn 228, Issue 2, 2012, Pages 230-240

  Carmona, F Javier ^a   Villanueva, Alberto ^a   Vidal, August ^b   Muñoz, Clara ^a   Puertas, Sara ^a   Penin, Rosa M ^b   Gomà, Montserrat ^b   Lujambio, Amaia ^a   Piulats, Josep M ^a   Mesía, Ricard ^a   Sánchez Céspedes, Montse ^a   Manós, Manel ^a   Condom, Enric ^b   Eccles, Suzanne A ^c   Esteller, Manel ^a,d,e  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

cadherin 11; DNA methylation; epigenetics; metastasis

Indexed keywords

CADHERIN; CADHERIN 11; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL LINE; CELL MOTILITY; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; GENE DISRUPTION; GENE SILENCING; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION TERMINATION;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; MICE; MICE, MUTANT STRAINS; MICROARRAY ANALYSIS; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866258177     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4011     Document Type: Article

References (42)

1. Jemal A, Siegel R, Xu J, et al., Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Fidler IJ,. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458.
3. Eccles SA, Welch DR,. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007; 369: 1742-1757.
4. Carmona FJ, Esteller M,. IDIBELL cancer conference on metastasis and angiogenesis. Cancer Res 2011; 71: 6097-7101.
5. Ma L, Teruya-Feldstein J, Weinberg RA,. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688.
6. Nguyen DX, Chiang AC, Zhang XH, et al., WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009; 138: 51-62.
7. Sleeman JP,. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 2000; 157: 55-81.
8. Jackson DG,. Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis. Cancer Treat Res 2007; 135: 39-53.
9. Chaffer CL, Weinberg RA,. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.
10. Esteller M,. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
11. Rodríguez-Paredes M, Esteller M,. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-339.
12. Fernandez AF, Assenov Y, Martin-Subero JI, et al., A DNA methylation fingerprint of 1628 human samples. Genome Res 2012; 22: 407-419.
13. Fang F, Turcan S, Rimner A, et al., Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011; 3: 75ra25.
14. Hill VK, Ricketts C, Bieche I, et al., Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 2011; 71: 2988-2999.
15. Lujambio A, Calin GA, Villanueva A, et al., A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105: 13556-13561.
16. Png KJ, Yoshida M, Zhang XH, et al., MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 2011; 25: 226-231.
17. Davalos V, Moutinho C, Villanueva A, et al., Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012; 31: 2062-2074.
18. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289-300.
19. Esteller M, Corn PG, Baylin SB, et al., A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-3229.
20. Myers JN, Holsinger CF, Jasser SA, et al., An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Can Res 2002; 8: 293-298.
21. Bibikova M, Lin Z, Zhou L, et al., High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16: 383-393.
22. Byun HM, Siegmund KD, Pan F, et al., Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum Mol Genet 2009; 18: 4808-4817.
23. Christensen BC, Houseman EA, Marsit CJ, et al., Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5: e1000602.
24. Takai D, Jones PA,. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99: 3740-3745.
25. Kashima T, Nakamura K, Kawaguchi J, et al., Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 2003; 104: 147-154.
26. Marchong MN, Chen D, Corson TW, et al., Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2004; 2: 495-503.
27. Nakajima G, Patino-Garcia A, Bruheim S, et al., CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genom Proteom 2008; 5: 37-42.
28. Chu K, Cheng CJ, Ye X, et al., Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 2008; 6: 1259-1267.
29. Jeanes A, Gottardi CJ, Yap AS,. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 2008; 27: 6920-6929.
30. Lee DM, Kiener HP, Agarwal SK, et al., Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007; 315: 1006-1010.
31. Kuijpers KA, Heesakkers JP, Jansen CF, et al., Cadherin-11 is expressed in detrusor smooth muscle cells and myofibroblasts of normal human bladder. Eur Urol 2007; 52: 1213-1221.
32. Borchers A, David R, Wedlich D,. Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification. Development 2001; 128: 3049-3060.
33. Van Marck V, Stove C, Jacobs K, et al., P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma. Int J Cancer 2011; 128: 1031-1044.
34. Pishvaian MJ, Feltes CM, Thompson P, et al., Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999; 59: 947-952.
35. Li Z, Zhou Z, Donahue HJ,. Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metast 2008; 25: 265-272.
36. Huang CF, Lira C, Chu K, et al., Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res 2010; 70: 4580-4589.
37. Marchong MN, Yurkowski C, Ma C, et al., Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death. PLoS Genet 2010; 6: e1000923.
38. Mueller DW, Bosserhoff AK,. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer 2011; 129: 1064-1074.
39. Cavallaro U, Christofori G,. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132.
40. Kawaguchi J, Takeshita S, Kashima T, et al., Expression and function of the splice variant of the human cadherin-11 gene in subordination to intact cadherin-11. J Bone Miner Res 1999; 14: 764-775.
41. Wyckoff JB, Pinner SE, Gschmeissner S, et al., ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 2006; 16: 1515-1523.
42. Ko JM, Fisher DE,. A new era: melanoma genetics and therapeutics. J Pathol 2011; 223: 241-250.